Area of research
Cancer Research · Reproductive Medicine
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Cancer Genomics and Diagnostics, and Breast Cancer Treatment Studies.
IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial
Targeted knockdown of PGAM5 in synovial macrophages efficiently alleviates osteoarthritis
ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer
MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway.
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
Overall survival (OS) in patients with platinum-sensitive relapsed ovarian cancer (PSROC) treated with olaparib maintenance monotherapy: Update from the L-MOCA trial.
Combined Single‐Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination
The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry
Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities
Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy.
Changes in the small noncoding RNA transcriptome in osteosarcoma cells
Temporal relationship of the orphan receptor TR3 translocation and expression with zinc-induced apoptosis in prostate cancer cells
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation
Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer
Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study
A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers
Changes in the Small Noncoding RNAome During M1 and M2 Macrophage Polarization
Small Noncoding RNAome Changes During Human Bone Marrow Mesenchymal Stem Cells Senescence In Vitro
Myricetin Induces Apoptosis and Protective Autophagy through Endoplasmic Reticulum Stress in Hepatocellular Carcinoma.
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
The trans-omics landscape of COVID-19
Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity.
Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing
Effect of Ki-67 Expression Levels and Histological Grade on Breast Cancer Early Relapse in Patients with Different Immunohistochemical-based Subtypes
Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19
DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway.
Chinese expert consensus on the prevention of abdominal pelvic adhesions after gynecological tumor surgeries